February 2025

FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk ()
Request for an American Board of Cardiovascular Medicine denied—cardiology groups ‘deeply disappointed’ ()
Why cardiac CT adoption remains low among primary care providers ()
Surgeons make history, perform world’s first living mitral valve replacement ()
FDA sued over ‘reckless and arbitrary’ semaglutide decision ()
Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities ()
FDA clears Google smartwatch tech that calls 911 when a user’s heart stops ()
Popular TAVR valves linked to comparable long-term outcomes ()
Wearable heart device company to go public, raise up to $155M ()
Detecting coronary inflammation on CT imaging could reshape preventive cardiology ()
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD ()
Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval ()
Know your options: What cardiologists recommend when alternative access is required for TAVR ()
Heart surgery during pregnancy: Tracking the safety of a rare, sometimes unavoidable, scenario ()
An updated look at the use of cerebral embolic protection devices during TAVR ()
AI leader Heartflow enters new era focused on delivering personalized care for CAD patients ()
Cardiovascular societies support Medicare coverage for renal denervation ()
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging ()
New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care ()
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary ()
Surgeons first in world to perform open heart surgery on baby mid-delivery ()
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic ()
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues ()
Cardiologist questions FDA’s approval process for high-risk medical devices ()
Getinge ending production of cardiopulmonary surgical perfusion systems ()
Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology ()
FDA approves first rapid-acting insulin biosimilar for diabetes ()
Aspartame linked to surging insulin levels, fatty plaques and inflammation ()
Sotagliflozin the first drug of its kind to limit heart attacks, strokes in high-risk patients ()
CABG still the ‘gold standard’ for revascularization in patients with 3-vessel CAD and CKD ()
Osteoporosis drug shows potential to treat heart disease ()
Johnson & Johnson resumes PFA rollout after stopping to review safety concerns ()
Veterans with heart disease often receive better care through VA than they would elsewhere ()
Opportunistic imaging detects signs of heart disease in lung cancer patients ()
LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients ()
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns ()
CABG, TAVR top list of most lucrative heart procedures for hospitals ()
Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options ()
HeartBeam raising $10M for FDA-cleared health tech with public offering ()
Johnson & Johnson MedTech launches new large-bore catheter system for stroke ()
Use of biolimus-coated balloons during PCI not as effective as paclitaxel devices ()
Report: Johnson & Johnson wants to sell its stroke business for more than $1B ()
Final decision on the creation of a new cardiovascular board expected soon ()
Interventional heart failure: An evolving cardiology subspecialty with a bright future ()
ACC president details key advocacy efforts in cardiology ()
Novartis to acquire drugmaker behind new heart therapy for up to $3.1B ()
Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome ()
Benzodiazepine use before heart surgery: Should it be embraced or restricted? ()
Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients ()
Women with severe aortic stenosis remain underdiagnosed, undertreated—here’s how cardiologists can make a difference ()
Family of heart patient who died after missing medications in jail settles lawsuit ()
ASE shares new guidelines for ultrasound-guided vascular access ()
AI brings cardiology, neurology teams together to boost care for stroke patients ()
FDA warns that atherectomy devices are breaking during use—30 serious injuries, 4 deaths reported ()
COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke ()
Post-stroke follow-up care considerably worse for women than men ()
THT 2025: Late-breaking clinical trials announced for CRF’s heart failure conference ()
FDA warns that smartphone-compatible diabetes devices may not work properly ()
Heart failure patients see benefits from home-based rehab ()
Oklahoma cardiologist and his clinic pay $270K to settle whistleblower lawsuit ()
Be good to your teeth: Regular flossing reduces risk of stroke, AFib ()
Ross procedure linked to high levels of safety, effectiveness after 20 years ()
Nearly half of U.S. adults are wrong about aspirin ()
Unifying IT to Improve Data Access, Physician Efficiency and KPI-driven Performance ()
TAVR patients admitted on weekend face greater risk of death, complications ()
More than words: AI takes NLP to the next level to identify signs of heart failure ()
Key details on the use of ICE to guide structural heart procedures ()
Cardiologists help highlight ‘severe consequences’ of peripheral artery disease ()